Adverse events associated with smallpox vaccination in the United States, January-October 2003

JAMA

Volumn 294, Issue 21, 2005, Pages 2734-2743

  Casey, Christine G ^a,d   Iskander, John K ^a,d   Roper, Martha H ^a,d   Mast, Eric E ^a,d   Wen, Xiao Jun ^a,d   Török, Thomas J ^a,d   Chapman, Louisa E ^a   Swerdlow, David L ^a,d   Morgan, Juliette ^a,d   Heffelfinger, James D ^a,d   Vitek, Charles ^a,d   Reef, Susan E ^a   Hasbrouck, La Mar ^a,d   Damon, Inger ^b   Neff, Linda ^a,d   Vellozzi, Claudia ^a,c   McCauley, Mary ^a   Strikas, Raymond A ^a,d   Mootrey, Gina ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Logistics Health Incorporated   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; SMALLPOX VACCINE;

ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; CARCINOMA; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEATH; DISABILITY; DISEASE TRANSMISSION; DOSE CALCULATION; DRUG MONITORING; DRUG RESPONSE; DRUG SAFETY; DYSPNEA; ECZEMA; ECZEMA VACCINATUM; ENCEPHALITIS; ENCEPHALOMYELITIS; ERYTHEMA MULTIFORME; FATIGUE; FEMALE; FETAL VACCINIA; FEVER; GENERALIZED VACCINIA; HEADACHE; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HOSPITALIZATION; HUMAN; HYPERTENSION; INFECTION; INFECTION PREVENTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NEUROLOGIC DISEASE; PAIN; PERICARDITIS; PRIORITY JOURNAL; PROGRESSIVE VACCINIA; PRURITUS; RASH; SIDE EFFECT; SKIN DISEASE; SMALLPOX; STEVENS JOHNSON SYNDROME; SUPERINFECTION; SYSTEMIC DISEASE; THORAX PAIN; TREATMENT OUTCOME; UNITED STATES; VACCINATION; VACCINIA; VOLUNTEER;

EID: 28844475184     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.21.2734     Document Type: Article

References (73)

1. Neff JM. The case for abolishing routine childhood smallpox vaccination in the United States. Am J Epidemiol. 1971;93:245-247.
2. Centers for Disease Control and Prevention. Smallpox vaccine: recommendations of the Public Health Service Immunization Practices Advisory Committee. MMWR Morb Mortal Wkly Rep. 1978;27:156-158,163-164.
3. World Health Organization. The global eradication of smallpox: final report of the global commission for the certification of smallpox eradication. In: History of International Public Health No. 4. Geneva, Switzerland: World Health Organization; 1980.
4. Centers for Disease Control and Prevention. Smallpox Response Plan and Guidelines (Version 3.0): November 2002. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2002. Available at: http://www.bt.cdc.gov/agent/smallpox/response-plan/index.asp. Accessed September 30, 2005.
5. Rotz LD, Dotson DA, Damon IK, Becher JA; Advisory Committee on Immunization Practices. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep. 2001;50(RR-10):1-25.
6. Wharton M, Strikas RA, Harpaz R, et al; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003;52(RR-7):1-16.
7. Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA. 2003;289:3278-3282.
8. 68 CFR §18 (2003):4212-4213.
9. Centers for Disease Control and Prevention. Update: adverse events following civilian smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:475-477.
10. Cono J, Casey CG, Bell DM; Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep. 2003;52(RR-4):1-28.
11. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and Its Eradication. Geneva, Switzerland: World Health Organization; 1988.
12. Neff JM, Lane JM, Pert JH, Moore R, Millar JD, Henderson DA. Complications of smallpox vaccination, I: national survey in the United States, 1963. N Engl J Med. 1967;276:125-132.
13. Neff JM, Levine RH, Lane JM, et al. Complications of smallpox vaccination United States 1963, II: results obtained by four statewide surveys. Pediatrics. 1967;39:916-923.
14. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med. 1969;281:1201-1208.
15. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis. 1970;122:303-309.
16. Bengtsson E, Lundstrom R. Postvaccinial myocarditis. Cardiologia. 1957;30:1-8.
17. Feery BJ. Adverse reactions after smallpox vaccination. Med J Aust. 1977;2:180-183.
18. Finlay-Jones L. Fatal myocarditis after vaccination against smallpox. N Engl J Med. 1964;270:41-42.
19. Helle EP, Koskenvuo K, Heikkila J, Pikkarainen J, Weskstrom P. Myocardial complications of immunizations. Ann Clin Res. 1978;10:280-287.
20. Karjalainen J, Heikkila J, Markku S, et al. Etiology of mild acute infectious myocarditis. Acta Med Scand. 1983;213:65-73.
21. Dolgopol V, Greenberg M, Arnoff R. Encephalitis following smallpox vaccination. Arch Neurol Psychiatry. 1955;73:216-223.
22. Cangemi V. Acute pericarditis after smallpox vaccination. N Engl J Med. 1958;258:1257-1259.
23. Mead J. Serum transaminase and electrocardiographic findings after smallpox vaccination: case report. J Am Geriatr Soc. 1966;14:754-756.
24. McNalley MC, Qamar Y. Cardiac complications of progressive generalized vaccinia: report of a case. Dis Chest. 1966;49:333-335.
25. Phillips M, Robinowitz M, Higgins JR, et al. Sudden cardiac death in Air Force recruits: a 20-year review. JAMA. 1986;256:2696-2699.
26. Centers for Disease Control and Prevention (CDC). Cardiac adverse events following smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:248-250.
27. Centers for Disease Control and Prevention. Health advisory: smallpox: people with known cardiac disease should not be vaccinated. Available at: http://www.phppo.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00129. Accessed September 30, 2005.
28. Centers for Disease Control and Prevention (CDC). Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2003;52:282-284.
29. Frey SE, Couch RB, Tacket CO, et al; National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346:1265-1274.
30. Tasker SA, Schnepf GA, Lim M, et al. Unintended smallpox vaccination of HIV-1-infected individuals in the United States military. Clin Infect Dis. 2004;38:1320-1322.
31. Greenberg RN, Schosser RH, Plummer EA, et al. Urticaria, exanthems, and other benign dermatologic reactions to smallpox vaccination in adults. Clin Infect Dis. 2004;38:958-965.
32. Talbot TR, Bredenberg K, Smith M, LaFleur B, Boyd A, Edwards K. Focal and generalized folliculitis following smallpox vaccination among vaccinia-naive recipients. JAMA. 2003;289:3290-3294.
33. Institute of Medicine of the National Academies; Committee on Smallpox Vaccination Program Implementation Board on Health Promotion and Disease Prevention. Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation Letter Report #1. Available at: http://www.nap.edu/html/smallpox_vac/ltr_report.pdf. Accessed September 30, 2005.
34. Centers for Disease Control and Prevention (CDC). Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program. MMWR Morb Mortal Wkly Rep. 2003;52:88-89, 99.
35. Centers for Disease Control and Prevention. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions: case definition, classification, and reporting. MMWR Morb Mortal Wkly Rep. In press.
36. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841-842.
37. Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA. 2005;294:2744-2750.
38. Vellozzi C, Lane JM, Averhoff F, et al. Generalized vaccinia, progressive vaccinia and eczema vaccinatum are rare following smallpox (vaccinia) vaccination: United States Surveillance, 2003. Clin Infect Dis. 2005;41:689-697.
39. Centers for Disease Control and Prevention (CDC). Update: cardiac-related events during the civilian smallpox vaccination program - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:492-496.
40. Klevens RM, Kupronis BA, Lawton R, et al; Hospital Smallpox Vaccination-Monitoring System Team. Monitoring health care workers after smallpox vaccination: findings from the hospital smallpox vaccination-monitoring system. Am J Infect Control. 2005;33:315-319.
41. Sejvar J, Boneva R, Lane JM, Iskander J. Severe headaches following smallpox vaccination. Headache. 2005;45:87-88.
42. Muralles AA, Ray P, Black S, et al; CISA Network. Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients [published online ahead of print August 30, 2005]. Vaccine. doi:10.1016/j.vaccine.2005.07.089.
43. Centers for Disease Control and Prevention (CDC). Women with smallpox vaccine exposure during pregnancy reported to the National Smallpox Vaccine in Pregnancy Registry - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:386-388.
44. Centers for Disease Control and Prevention. CDC clinician registry for terrorism and emergency response updates and training opportunities. Available at: http://www.bt.cdc.gov/clinregistry/index.asp. Accessed September 30, 2005.
45. Gerberding J. Transcript: CDC smallpox vaccination update. Available at: http://www.cdc.gov/od/oc/media/transcripts/t030117.htm. Accessed September 30, 2005.
46. State Health Department Training: Smallpox Vaccine Adverse Event Workshop. Atlanta, Ga: State Health Dept; January 22-23, 2003.
47. Centers for Disease Control and Prevention. Smallpox and vaccinia laboratory testing: a national training initiative. Available at: http://www.bt.cdc.gov/agent/smallpox/training/webcast/29jan2003/index.asp. Accessed September 30, 2005.
48. Centers for Disease Control and Prevention. Small-pox pre-vaccination information packet. Available at: http://www.bt.cdc.gov/agent/smallpox/ vaccination/infopacket.asp. Accessed September 30, 2005.
49. Copeman PW, Wallace HJ. Eczema vaccinatum. BMJ. 1964;2:906-908.
50. Bray M, Wright M. Progressive vaccinia. Clin Infect Dis. 2003;36:766-774.
51. Lane JM, Ruben FL, Abrutyn E, Millar JD. Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968. JAMA. 1970;212:441-444.
52. Naleway A, Belongia E, Greenlee R, Kieke B, Chen R, Shay D. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med. 2003;139:1-7.
53. Centers for Disease Control and Prevention. Clinician Information Line. Available at: http://www.bt.cdc.gov/coca/cil.asp. Accessed September 30, 2005.
54. Coding Symbols for Thesaurus of Adverse Reaction Terms (COSTART). 5th ed. Rockville, Md: US Food and Drug Administration, Center for Drug Evaluation and Research; 1995.
55. Postmarketing Reporting of Adverse Experiences, 21 CFR §600.80. Available at: http://www .accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch.cfm?FR=600.80. Accessed September 30, 2005.
56. VAERS Continuing Education. Vaccine safety postmarketing surveillance: the Vaccine Adverse Event Reporting System. Available at: http://vaers.hhs.gov/ ce.htm. Accessibility verified October 25, 2005.
57. Kaydos-Daniels SC, Bixler D, Colsher P, et al. Symptoms following smallpox vaccination-West Virginia, 2003. Presented at: 53rd Annual Epidemic Intelligence Service Conference; April 19-23, 2004;Atlanta, Ga.
58. Baggs J, Chen RT, Damon IK, et al. Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program. Clin Infect Dis. 2005;40:1133-1140.
59. Belongia EA, Naleway A, Kieke B, et al. Validation of a screening instrument to identify persons for exclusion from smallpox vaccination. Clin Infect Dis. 2005;40:620-623.
60. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365-372.
61. O'Connor S, Taylor Ch, Campbell LA, Epstein S, Libby P. Potential infectious etiologies of ahterosclerosis: a multifactorial perspective. Emerg Infect Dis. 2001;7:780-788.
62. Chen RT, Lane JM. Myocarditis: the unexpected return of smallpox vaccine adverse events. Lancet. 2003;362:1345-1346.
63. Arness MK, Eckart RE, Love SS, et al. Myopericarditis following smallpox vaccination. Am J Epidemiol. 2004;160:642-651.
64. Mason JW. Myocarditis. Adv Intern Med. 1999;44:293-310.
65. Feldman AM, McNamara D. Medical progress: myocarditis. N Engl J Med. 2000;343:1388-1398.
66. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331:1564-1575.
67. Teutsch SM, Churchill RE, eds. Principles and Practice of Public Health Surveillance. Oxford, England: Oxford University Press; 2000.
68. Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995;85:1706-1709.
69. Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 2004;23:287-294.
70. Iskander J, Casey C, Roper M, et al. Serious adverse events following smallpox vaccination among U.S. civilians [abstract]. Pharmacoepidemiol Drug Saf. 2004;13:S276-S277.
71. Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol Drug Saf. 2002;11:189-202.
72. Murphy TV, Gargiullo PM, Massoudi MS, et al; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564-572.
73. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia: transmission of vaccinia from smallpox vaccination. JAMA. 2002;288:1901-1905.